AVE 25.0% 0.3¢ avecho biotechnology limited

financial misappropriation ann is out, page-84

  1. 1,290 Posts.
    lightbulb Created with Sketch. 5
    Dtermin8n, I think you are a little off the mark!

    In the last year we have license agreements with big companies like Agila and Novartis! If you think the science is dodgy, I suggest you take it up with these companies!

    POH has licensed an injectable antibiotic product, harnessing its proprietary TPM® platform technology, to Agila Specialties Private Limited (Agila).

    http://hotcopper.com.au/announcementFiles/2012/POH/cd92483d-5287-4552-bde1-5fceb20a3d31-POH381376.pdf

    License and Supply Agreement between Themis Medicare Limited (“Themis”)and Novartis India Limited (“Novartis”), Themis has agreed to manufacture and supply and Novartis has agreed to purchase from Themis diclofenac topical gel
    formulated using a unique TPM® transdermal drug delivery system, in finished dosage pharmaceutical form on certain commercial terms and conditions.

    http://hotcopper.com.au/announcementFiles/2013/POH/2762871a-204a-4588-9b56-edf8fc196138-POH388341.pdf

    Trade Safe!

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(25.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $2.035K 678.4K

Buyers (Bids)

No. Vol. Price($)
28 40284733 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 39213269 30
View Market Depth
Last trade - 13.19pm 13/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.